Instem plc Issue of Equity and Total Voting Rights (6343E)
May 09 2017 - 8:25AM
UK Regulatory
TIDMINS
RNS Number : 6343E
Instem plc
09 May 2017
Instem plc
("Instem" or the "Company")
Issue of Equity and Total Voting Rights
Instem plc (AIM: INS), a leading provider of IT solutions to the
global early development healthcare market, announces that,
following the exercise of share options by an employee, 5,154
ordinary shares of 10p each in the Company ("Ordinary Shares") have
been issued.
Application will be made to the London Stock Exchange for the
admission of the 5,154 new Ordinary Shares to trading on AIM and
admission is expected to take place at 8.00 a.m. on 15 May
2017.
Total Voting Rights
Following the issue and allotment of the above new Ordinary
Shares, the Company's issued share capital comprises 15,776,552
Ordinary Shares. The Company does not hold any Ordinary Shares in
treasury. Therefore the total number of voting rights in the
Company is 15,776,552.
The figure of 15,776,552 may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change of their
interest in, the Company under the FCA's Disclosure and
Transparency Rules.
For further information, please contact:
Instem plc +44 (0) 1785 825 600
Phil Reason, CEO
Nigel Goldsmith, CFO
N+1 Singer (Nominated
Adviser & Broker) +44 (0) 20 7496 3000
Richard Lindley
Nick Owen
James White
Walbrook Financial PR +44 (0) 20 7933 8780
Paul Cornelius instem@walbrookpr.com
Helen Cresswell
Sam Allen
Paul Whittington
About Instem
Instem is a leading supplier of IT applications and services to
the early development healthcare market delivering compelling
solutions for data collection, analysis and regulatory submissions
management. Instem solutions are in use by customers worldwide,
meeting the rapidly expanding needs of life science and healthcare
organisations for data-driven decision making leading to safer,
more effective products.
Instem's portfolio of software solutions increases client
productivity by automating study-related processes while offering
the unique ability to generate new knowledge through the extraction
and harmonisation of actionable scientific information.
Instem supports over 500 clients through offices in the United
States, United Kingdom, France, Japan, China and India.
To learn more about Instem solutions and its mission, please
visit www.instem.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEADSNEALXEFF
(END) Dow Jones Newswires
May 09, 2017 09:25 ET (13:25 GMT)
Instem (LSE:INS)
Historical Stock Chart
From Apr 2024 to May 2024
Instem (LSE:INS)
Historical Stock Chart
From May 2023 to May 2024